⭐️⭐️⭐️⭐️⭐️ "A total no brainer"

⭐️⭐️⭐️⭐️⭐️ "Love this, so easy."

Spots is the easy way to track your skin, mole and cancer changes.

Spots Global Cancer Trial Database for Radiofrequency Ablation Versus I-131 for Solitary Autonomous Thyroid Nodules

The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.

Trial Identification

Brief Title: Radiofrequency Ablation Versus I-131 for Solitary Autonomous Thyroid Nodules

Official Title: Ultrasound-guided Radiofrequency Ablation Versus Radioactive Iodine as Treatment for Hyperthyroidism Caused by Solitary Autonomous Thyroid Nodules

Study ID: NCT05142904

Study Description

Brief Summary: The purpose of this study is to compare treatment of hyperthyroidism with radiofrequency ablation or I-131 for solitary autonomous thyroid nodules.

Detailed Description:

Keywords

Eligibility

Minimum Age: 18 Years

Eligible Ages: ADULT, OLDER_ADULT

Sex: ALL

Healthy Volunteers: No

Locations

Ziekenhuis Groep Twente, Almelo, Gelderland, Netherlands

Rijnstate Hospital, Arnhem, Gelderland, Netherlands

Amphia Hospital, Breda, Noord-Brabant, Netherlands

Catharina Hospital, Eindhoven, Noord-Brabant, Netherlands

Elkerliek Hospital, Helmond, Noord-Brabant, Netherlands

Amsterdam UMC, location VUMC, Amsterdam, Noord-Holland, Netherlands

Spaarne Gasthuis, Hoofddorp, Noord-Holland, Netherlands

Albert Schweiter Hospital, Dordrecht, Zuid Holland, Netherlands

Haga Ziekenhuizen, Zoetermeer, Zuid Holland, Netherlands

Martini Hospital, Groningen, , Netherlands

Contact Details

Useful links and downloads for this trial

Clinicaltrials.gov

Google Search Results

Logo

Take Control of Your Skin and Body Changes Today.

Try out Spots for free, set up only takes 2 mins.

spots app storespots app store

Join others from around the world: